secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001493152-25-021323
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions reports preliminary Q1 FY2026 revenue over $1M, up ~32% sequentially
--------------------------------------------------------------------------------

- Preliminary revenue >$1M for fiscal Q1 ended Sep 30, 2025; third consecutive quarter of growth.
- Revenue up ~32% sequentially and ~28% year-over-year.
- Cartridge revenue up ~43% YoY; reader revenue up ~23% YoY.
- Growth driven by new customer accounts and strong sales of both cartridges and readers.
- Full Q1 financial results expected in 10-Q filing week of Nov 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225021323/0001493152-25-021323-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225021323/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-021323

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer